Medical Marijuana Inc (MJNA)

[Rat Fink]

4/5/17 PR, MEXICAN_INDEPENDENT_STUDY_SHOWS_IMPRESSIVE_HEMPMEDS_RESULTS!!!

EXCERTR FROM PR AS FOLLOWS:

SAN DIEGO, April 5, 2017 /PRNewswire/ -- Por Grace Foundation, a Mexican national reference of the fight to gain access to cannabis derived products for the treatment of several neurodegenerative conditions, today announced the results of a new survey from the viewpoint of the parents of children with refractory epilepsy (RE). Conducted by renowned Mexico Physician Dr. Carlos G. Aguirre Velazquez, the study found that out of 43 cases of children who were treated with cannabidiol (CBD) hemp oil, over 81% showed a reduction in convulsions. Additionally, these new study results have been published in Neurology Research International.

The product most commonly used in the survey was Medical Marijuana, Inc.'s (MJNA) subsidiary HempMeds® Mexico's flagship product, Real Scientific Hemp Oil-X™ (RSHO-X™). RSHO-X™ was the first product to receive COFEPRIS approval for import into Mexico and is 100% THC-free.

The survey, which was the first observational study carried out in Mexico exploring the use of medicinal cannabis in pediatric RE, also reported that out of the 43 cases 51% showed a significant decrease in convulsions (greater than 75% reduction), while 16% reported being completely seizure free. Further, 9 out of the 43 cases reduced the anti-epileptic drugs they were using and zero serious side effects reported.

In addition, the survey reported an overall increased quality of life of the patients with 88% showing improved cognition, 86% showing improved emotions or mood, 77% showing an improvement in sleep, and 67% showing a better appetite.